Response to "clinically actionable genotypes among Brazilians"

Affiliations

¹ 1] Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, USA [2] Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.
² 1] Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA [2] Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.

Comment

S L Van Driest et al. Clin Pharmacol Ther. 2014 Jul.

. 2014 Jul;96(1):26.

doi: 10.1038/clpt.2014.71. Epub 2014 Mar 28.

¹ 1] Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, USA [2] Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.
² 1] Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA [2] Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.

No abstract available

Comment on

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
Van Driest SL, Shi Y, Bowton EA, Schildcrout JS, Peterson JF, Pulley J, Denny JC, Roden DM. Van Driest SL, et al. Clin Pharmacol Ther. 2014 Apr;95(4):423-31. doi: 10.1038/clpt.2013.229. Epub 2013 Nov 19. Clin Pharmacol Ther. 2014. PMID: 24253661 Free PMC article.
Clinically actionable genotypes among Brazilians.
Suarez-Kurtz G. Suarez-Kurtz G. Clin Pharmacol Ther. 2014 Jul;96(1):25-6. doi: 10.1038/clpt.2014.56. Epub 2014 Mar 5. Clin Pharmacol Ther. 2014. PMID: 24598719 No abstract available.